Literature DB >> 32274112

Decision algorithm and surgical strategies for managing tracheocutaneous fistula.

Chieh-Ni Kao1, Yu-Wei Liu2, Po-Chih Chang2,3, Shah-Hwa Chou2,3, Su-Shin Lee1,3,4, Yur-Ren Kuo1,3,4, Shu-Hung Huang1,3,4.   

Abstract

BACKGROUND: Persistent tracheocutaneous fistula (TCF) is a complication of prolonged use of tracheostomy tube. Although many procedures exist to correct this issue, there is no consensus regarding its optimal management. We constructed a decision algorithm to determine appropriate surgical strategies for TCF repair.
METHODS: Retrospectively reviewing our hospital's records, we found fourteen consecutive patients who had received surgical repair of tracheocutaneous fistula (primary closure or advanced local flap) between February 2013 and December 2018 and collected data relevant to their cases.
RESULTS: We identified 11 male and 3 female patients. Duration of tracheostomy dependence was 8.1±4.7 months, and timespan from decannulation to surgical closure 7.4±6.5 months. Seven patients received primary closures, six received hinged turnover flaps, and one received random and perforator flap reconstruction. There was no perioperative mortality or morbidity except for one patient requiring a repeat tracheostomy 11 months after TCF repair due to pneumonia and subsequent respiratory failure. We used our findings and those reported in the literature to construct a modified risk factor scoring system based on patient's physical status, major comorbidities, perifistular soft tissue condition, and nutritional status and an algorithm for managing TCF based on the patients' fistula size and modified risk factor scores.
CONCLUSIONS: In conclusion, we were able to review our cases and those of other studies to create a risk scoring system and a decision algorithm that we believe will help optimize patient-directed surgical management of TCF repair. 2020 Journal of Thoracic Disease. All rights reserved.

Entities:  

Keywords:  Tracheocutaneous fistula; algorithm; strategy; surgery; tracheostomy

Year:  2020        PMID: 32274112      PMCID: PMC7138993          DOI: 10.21037/jtd.2020.01.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


Introduction

Tracheostomies are frequently performed during the treatment of critically ill patients in intensive care (1). Decannulation methods vary depending on a patient’s ability to tolerate certain procedures and physician’s experience. In most cases, a simple removal of the tube and the application of occlusive dressings produce acceptable functional and aesthetic results (2). However, the procedure is performed with some risk of subsequent development of tracheocutaneous fistulas (TCF), which develop when the squamous epithelium migrates into the trachea creating an epithelialized tract that fails to close. Kulber et al. have reported that 70% of adult patients who have tracheostomies for more than 16 weeks end up with TCFs (3). It has also been reported that 13% to 43% of children with tracheostomies develop TCFs after decannulation (4). Prolonged cannulation can significantly increase the risk of persistent fistulas, which can then lead to difficulties in vocalization and secretion clearance, and recurrent respiratory infections as well as social and cosmetic problems (5). Thus, TCFs often require local wound care and plastic reconstruction. Our review of the literature revealed that TCFs can be corrected using several surgical techniques, including electrocautery (4), primary closure with or without fistulectomy (5,6), use of a hinged turnover flap or an additional V-Y advancement flap (7-9), and harvest of auricular or rib cartilage transplanted to the tracheal defect with muscle and fasciocutaneous flaps (10-12). Each procedure has its own advantage and is used depending on individual patient needs and TCF characteristics, and choice of which procedure to use largely depends on expert opinion. However, we found very little consensus regarding the optimal management of TCF. Therefore, although cases are rare in number, our team set out to create an algorithm to help us decide on the most appropriate surgical strategy for repairing TCF based on the characteristics of previous cases reported in the literature and a retrospective review of cases at our hospital from 2013 to 2018.

Methods

Study design and patients

This retrospective study was approved by the institutional review board of Kaohsiung Medical University Hospital [approval number: KMUHIRB-E(I)-20190146]. Because the study was retrospective in design, the need for informed consent was waived. Our patient cases, mostly treated in our thoracic surgery and plastic surgery divisions, were referred to us for surgical repair of TCF if spontaneous closure of the fistula had not occurred after at least three months after decannulation of tracheostomy tubes or if the patient requested help resolving an unsightly cosmesis, weak cough, recurrent skin irritation related to draining secretions, or constraints on their daily activities. Searching our hospital’s medical records, we identified fourteen patients that had received TCF repairs between February 2013 and December 2018 at our hospital. We collected and analyzed several clinically-relevant variables, including demographic characteristics, precipitating factors for tracheostomy, duration of tracheostomy dependence, timespan between cannulation to surgical closure, preoperative assessment, fistula size, operative techniques, operative time, and hospital length of stay. Prior to TCF repair, fiberoptic bronchoscopy was used to evaluate each patient’s airway to ensure there were no tracheal abnormalities, such as tracheomalacia or granulation growth, that may need to be resolved before initiating surgery. Computed tomography of the neck or chest as well as preoperative overnight oximetry with the fistula occlusion test was selectively performed based on individual need. All the patients received surgical repair of TCF either under local anesthesia or general anesthesia depending on which, according to surgeon’s clinical judgment, would be most appropriate for fistula size and patient condition. After surgery, all patients were advised to return for regular outpatient clinic visits. All of the cases were followed until January 2019.

Representative TCF repair under general anesthesia

Patient No. 8

Case 8 involved a 33-year-old man who had been dependent on tracheostomy for 16 months following a traumatic brain injury. After decannulation, a TCF had developed and was found to remain at an unreduced size of 10-mm at 14 months (). The patient sought TCF repair because he had great difficulty speaking, coughing, and showering.
Figure 1

Surgical repair for Patient No.8 with tracheocutaneous fistula. (A) The TCF size was measured around 10 mm. (B) Dissection proceeded through to the peritracheal area, preserving an area of fibrotic subcutaneous tissue around the fistula (yellow arrows). (C) The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (yellow arrows). (D) The subcutaneous tissues around the fistula were then sutured with 4-0 vicryl using multiple layered sutures to invaginate the hinged flaps into the fistula (yellow arrows).

Surgical repair for Patient No.8 with tracheocutaneous fistula. (A) The TCF size was measured around 10 mm. (B) Dissection proceeded through to the peritracheal area, preserving an area of fibrotic subcutaneous tissue around the fistula (yellow arrows). (C) The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (yellow arrows). (D) The subcutaneous tissues around the fistula were then sutured with 4-0 vicryl using multiple layered sutures to invaginate the hinged flaps into the fistula (yellow arrows). Because the patient’s persistent TCF was large and might require more complex procedures, it was decided the TCF would be performed under general anesthesia. The patient was placed in a supine position with neck extended and intubated using a single endotracheal tube. One spindle-shaped incision was made around the TCF. The surgeon prepared three skin flaps to cover the skin defect: two hinge flaps for the right and left side of the fistula, respectively, and a third flap (advanced flap) to the right of the hinge flaps to eventually cover the whole area. Dissection proceeded through to the peritracheal area, preserving an area of fibrotic subcutaneous tissue around the fistula (). The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (). The subcutaneous tissues around the fistula were then sutured with 4-0 vicryl, using multiple layered sutures to invaginate or embed the hinged flaps into the fistula (). Following flap design and identification of perforator by hand-held doppler, a perforator-based transposition flap was rotated into the closed fistula, fixed, and finally closed with 5-0 nylon (). shows the wound 1 month after surgery during follow-up in an outpatient clinic.
Figure 2

Surgical repair for Patient No.8 with TCF and postoperative follow-up wound condition. (A) Following flap design and identification of perforator by hand-held doppler, a perforator-based transposition flap was rotated into the closed fistula and fixed. (B) Wound closed with 5-0 nylon. (C) Day 30 postoperative wound.

Surgical repair for Patient No.8 with TCF and postoperative follow-up wound condition. (A) Following flap design and identification of perforator by hand-held doppler, a perforator-based transposition flap was rotated into the closed fistula and fixed. (B) Wound closed with 5-0 nylon. (C) Day 30 postoperative wound.

Representative TCF repair under local anesthesia

Patient No. 9

Case 9 involved a 54-year-old woman who had been dependent on tracheostomy for 6 months after a traumatic brain injury. After decannulation, she was found to have developed an TCF. Eight months later, although the size of the fistula had reduced somewhat, the patient requested TCF repair to improve its appearance and reduce build-up of secretions around it. At that time, it had reduced to <5-mm in size (). Surgical repair was performed much as it was performed in Patient 8 mentioned above. Fistula and the surrounding skin were injected within 2% lidocaine combined with 1:100 epinephrine, to a total volume of less than 10 mL. One smaller spindle-shaped incision was made around the TCF after identification via needlestick probe and routine lidocaine spray through the probe was performed to reduce the cough reflex and secretion (). Three skin flaps were prepared (two hinge flaps on the right and left sides of the fistula and a third flap to the right of the hinge flaps) to cover the fistula. Then, dissection continued down to the peritracheal area, preserving an area of fibrotic subcutaneous tissue around the fistula (). At this stage, however, the fistula was measured to determine whether a fistulectomy due to redundancy would be necessary. In this case, fistulectomy was performed. The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (). The subcutaneous tissues around the fistula were then sutured with 4-0 vicryl, using layered sutures to invaginate the hinged flaps into the fistula followed by wound closure with 5-0 nylon.
Figure 3

Surgical repair for patient No. 9 with tracheocutaneous fistula. (A) The TCF measured <5 mm. (B) TCF was identified via needlestick probe insertion followed by routine lidocaine spray through the probe and creation of a smaller spindle-shaped incision around the TCF. (C) The fistula was observed and fistulectomy was performed after dissection through to the peritracheal area. (D) The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (yellow arrows).

Surgical repair for patient No. 9 with tracheocutaneous fistula. (A) The TCF measured <5 mm. (B) TCF was identified via needlestick probe insertion followed by routine lidocaine spray through the probe and creation of a smaller spindle-shaped incision around the TCF. (C) The fistula was observed and fistulectomy was performed after dissection through to the peritracheal area. (D) The hinged turnover flaps were sutured with 4-0 polydioxanone to make an inner lining for the trachea to cover the tracheal lumen with skin epithelium (yellow arrows).

Risk stratification scoring system

In addition to the length of time with tracheostomy, there are other factors related to risk of persistent fistula, including age, radiation, history of previous tracheotomy, and obesity (13,14). We searched the literature regarding the risk factors related to wound healing (15,16) and reviewed our cases to identify factors potentially contributing to the formation of TCFs, and found reported contributing factors to fall within four categories: patient’s physical status, major comorbidity, perifistular soft tissue condition, and nutritional status. We therefore construct a tentative risk stratification scoring system ().
Table 1

Risk stratification scoring system

CategoryScore
Patient’s physical status
   Elderly >65-year-old1
   ECOG: 2–41
Major comorbidity
   Poorly controlled diabetes mellitus*1
   End-stage renal disease with hemodialysis1
   Head & neck cancer history1
Perifistular soft tissue condition
   Previous tracheostomy1
   Severe peristomal scarring1
   Prior radiation of the neck1
Nutritional status
   Obesity (BMI >30)1
   Hypoalbuminemia (albumin <3.5)1
Risk stratification and scoring
   Low-risk patients: appropriate and safe for conservative treatment without additional surgical care0–3
   Intermediate-risk patients: needing close observation and further evaluation4–6
   High-risk patients: associated with an increased rate of persistent fistula needing additional evaluation and/or surgical intervention7–10

*Poorly controlled DM defined as an uninterrupted Hemoglobin A1c (HbA1c) ≥8.0% for ≥1 year despite standard care. ECOG, Eastern Cooperative Oncology Group Performance Status; BMI, body mass index.

*Poorly controlled DM defined as an uninterrupted Hemoglobin A1c (HbA1c) ≥8.0% for ≥1 year despite standard care. ECOG, Eastern Cooperative Oncology Group Performance Status; BMI, body mass index.

Statistical analysis

Patient characteristics were analyzed descriptively and expressed as mean ± standard deviation. All statistical operations were performed using SPSS 20 (SPSS Inc., Chicago, IL, USA) for Windows.

Results

The cases we identified at our hospital consisted of eleven male and three female patients aged 58.6±19.0 years. Prolonged mechanical ventilation necessitating tracheostomies were needed in five patients who had brain injuries incurred in motor vehicle collisions, eight patients who had complications related to surgical operations, and one who had an inhalation injury. Mean duration of tracheostomy dependence was 8.1±4.7 months, and mean time interval from decannulation to surgical of TCF 7.4±6.5 months. Simple primary closures with fistulectomies were performed in seven, hinged turnover flap with fistulectomies in six, and perforator flap reconstruction in one tailored to the fistula size and perifistular soft tissue condition. Mean operative time was 38.6±15.6 minutes and mean post-operative hospital length of stay 2.3±2.2 days ().
Table 2

Characteristics of patients underwent TCF repair

Case No.AgeGenderPrecipitating factorsFistula sizeDuration of tracheostomy (month)Timespan between decannulation to surgery (month)Operative techniqueOperative time (min)Post-operative hospital stay (day)Follow-up condition
183MRespiratory failure, status post cardiac surgery5–10 mm53Hinged turnover flap404Uneventful
273FInhalation injury5–10 mm165Hinged turnover flap502Uneventful
362MTraumatic brain injury<5 mm55Primary closure304Uneventful
427MTraumatic brain injury5-10 mm1216Hinged turnover flap402Uneventful
523MTraumatic brain injury<5 mm1224Primary closure307Uneventful
680FRespiratory failure, status post abdominal surgery<5 mm43Primary closure202Uneventful
751MRespiratory failure, status post esophageal surgery<5 mm43Primary closure200 (day surgery)Uneventful
837MTraumatic brain injury5–10 mm1614Perforator flap reconstruction804Repeat tracheostomy 11months after surgery
954FTraumatic brain injury<5 mm68Hinged turnover flap500 (day surgery)Uneventful
1073MRespiratory failure, status post abdominal surgery<5 mm53Primary closure400 (day surgery)Uneventful
1172MRespiratory failure, status post cardiac surgery<5 mm143Primary closure300 (day surgery)Uneventful
1257MRespiratory failure, related to postoperative myasthenic crisis in a thymoma patient5–10 mm610Hinged turnover flap503Uneventful
1374MRespiratory failure, status post abdominal surgery<5 mm53Primary closure300 (day surgery)Uneventful
1455MRepeated tracheostomy following tongue flap reconstruction in tongue cancer<5 mm43Hinged turnover flap304Uneventful
All patients had uneventful recoveries. During the follow-up period, which ranged from 1 to 71 months, there were no surgery-related complications or incomplete closures of TCF. However, one patient required a repeat tracheostomy 11 months after TCF repair due to pneumonia and subsequent respiratory failure necessitating prolonged ventilator support. The remaining thirteen patients has had complete fistula closures with no complications recorded during the follow-up period. According to our constructed risk stratification scoring system () in which a score of 0–3 was assigned to low-risk patients for whom conservative treatment without additional surgical care would be safe and adequate, a score of 4–6 was assigned to intermediate-risk patients needing close observation and further evaluation before treatment plan is decided, and score of 7–10 was assigned to high-risk patients with an increased rate of persistent fistula needing additional evaluation and/or surgical intervention. Based on this system, eight of our fourteen patients could be considered low-risk patients, five intermediate-risk patients, and one a high-risk patient.

Discussion

Persistent tracheocutaneous fistula is not uncommon following prolonged cannulations of tracheostomy. The duration of cannulation and a history of multiple tracheostomies are known to increase risk of persistent tracheocutaneous fistulas. Extending the duration of cannulation allows time for epithelial tissue to grow within the stoma and form epithelialized scar tissue and dense connective tissue, which results in persistent stoma. Fifty percent of patients cannulated for more than a year after a tracheostomy develop persistent tracheocutaneous fistulas (4). Surgery remains a mainstay treatment for TCF repair. A wide array of surgical techniques for closing TCF have been used and reported to have favorable outcomes. They range from simple use of primary closure to use of a hinged turnover flap and even to use of a harvested auricular or rib cartilage to repair the large fistula defect (4-7,9-12,14,17). Despite the great number of procedures that have been used, it remains unclear what optimal management of TCF would look like given the variety of scenarios. Although cases are few in number, we constructed a decision algorithm () for managing TCF based on fistula size and above-mentioned risk factors. After at least 3 months follow-up, patients with TCF are reassessed and further divided into group A (TCF size <5 mm with spontaneous closure); group B (TCF size <5 mm without spontaneous closure); group C (TCF size 5–10 mm); and group D (TCF size >10 mm). Group A consists of patients with small TCFs (<5 mm) after decannulation, all ultimately healing spontaneously within the observation time period. Groups B and C consisted of those with small TCFs (<5 mm) without spontaneous closure suitable for primary closure and those with fistula sizes 5–10 mm suitable for procedures in which the local flap technique is performed. There is no consensus in the literature regarding the best recommended surgical strategies for fistulas of different sizes. However, there are some case studies that report that patients with the TCFs larger than 10 mm, those with poor skin elasticity, those with deep retraction of lateral tracheal walls, and post-radiation of the neck may require more complex surgical techniques, including transplantation of an ear or rib cartilage graft and tracheal stent placement (10-12). These were performed to ensure complete closure of the fistula, which may not be achieved by turnover flaps, muscular interpositions, or free flaps alone (7-9). Patients with large TCFs (>10 mm) were categorized into a group D, patients who might be in need of such complex procedures.
Figure 4

Decision algorithm for tracheocutaneous fistula (TCF).

Decision algorithm for tracheocutaneous fistula (TCF). Five of our fourteen patients had small TCFs (size: <5 mm) and received fistula repairs under local anesthesia. They all recovered uneventfully and were discharged on the same day. Likewise, other studies have reported the successful TCF repair under local anesthesia. For example, Khaja et al. reported using primary multilayer closure under local anesthesia to successfully repair persistent TCF in 12 of 13 cases (18). Hernot et al., comparing use of rhomboid flap with use of Z plasty to repair fistulas in a case series of forty patients, reported that only eight of their patients had superficial wound complications (wound infection or skin necrosis) and those eight eventually recovered by secondary healing (19). Therefore, based on our experience and these studies, not all patients requiring surgical TCF repair need general anesthesia. With careful patient selection and choice of proper surgical technique, general anesthesia can be omitted. Although our patients did not develop subcutaneous emphysema, pneumothorax, or pneumomediastinum after TCF repair, there may be some risk of these adverse events. Therefore, a thorough preoperative survey is needed to help ensure successful surgical closure and uneventful recovery. Rennekampff et al. advocate fiberoptical visualization of the airway to preclude functional obstruction or constriction prior to performing the surgical closure of TCFs. Infections and foreign bodies should be treated well in advance of closure (20). Pulmonary function tests with measurement of the forced vital capacity is also prudent before definite closure. Geyer et al. advised preoperative overnight oximetry with the fistula occluded to identify patients who still rely on their fistula to breathe, thus avoiding the need for emergency re-cannulation (21). If these precautions are taken, then successful surgical closure can be performed safely and efficiently using the risk factor score and decision algorithm we created to for the surgical repair of TCFs. This study has some limitations, including its retrospective design, small sample size, and selection bias when it came to choice of surgical strategy chosen for the individual patient. Further prospective studies or studies with larger sample sizes are necessary to draw firm conclusions about the optimal surgical repair of TCFs.

Conclusions

To the best of our knowledge, this study is the first to describe the management of TCF using a decision algorithm in conjunction with a modified risk scoring system. With an increasing number of patients in the intensive care units undergoing early tracheostomy, it is inevitable that incidence of TCF will continue to increase. It is hoped that outcomes can be improved with the use of this decision algorithm and appropriate surgical strategies.
  21 in total

1.  A persistent tracheocutaneous fistula closed with two hinged skin flaps and rib cartilage interpositional grafting.

Authors:  Francesco Paolo Caronia; Alfonso Fiorelli; Mario Santini; Sergio Castorina
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-10

2.  Management of radiation-induced tracheocutaneous tissue defects by transplantation of an ear cartilage graft and deltopectoral flap.

Authors:  Frank Riedel; Ulrich Reinhart Goessler; Stephan Grupp; Gregor Bran; Karl Hörmann; Thomas Verse
Journal:  Auris Nasus Larynx       Date:  2005-09-23       Impact factor: 1.863

3.  Tracheocutaneous fistula repair with autologous auricular cartilage cap graft.

Authors:  Robert J Yawn; James R Yawn; Alexander Gelbard; Christopher T Wootten
Journal:  Laryngoscope       Date:  2016-06-13       Impact factor: 3.325

4.  Closure of a tracheocutaneous fistula by two hinged turnover skin flaps and a muscle flap: A case report.

Authors:  Yukihiro Tatekawa; Hiroaki Yamanaka; Toshimichi Hasegawa
Journal:  Int J Surg Case Rep       Date:  2012-11-23

5.  Closure of large tracheocutaneous fistula using turn-over hinge flap and V-Y advancement flap.

Authors:  Ung-Joo Lee; Eui-Kyung Goh; Soo-Geun Wang; So-Min Hwang
Journal:  J Laryngol Otol       Date:  2002-08       Impact factor: 1.469

6.  Defect classification and reconstruction algorithm for patients with tracheostomy using the tunneled supraclavicular artery island flap.

Authors:  Norbert Pallua; Timm Phillip Wolter
Journal:  Langenbecks Arch Surg       Date:  2010-06-19       Impact factor: 3.445

7.  A novel technique for closing a tracheocutaneous fistula using a hinged skin flap.

Authors:  Mitsuhiro Kamiyoshihara; Toshiteru Nagashima; Izumi Takeyoshi
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

Review 8.  Wound Healing in Patients With Impaired Kidney Function.

Authors:  Natallia Maroz; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2014-06-08

9.  Primary closure of persistent tracheocutaneous fistula in children.

Authors:  K L Bressler; P C Kaiser; M E Dunham; L D Holinger
Journal:  Ann Otol Rhinol Laryngol       Date:  1994-11       Impact factor: 1.547

10.  Tracheocutaneous Fistula Closure: Comparison of Rhomboid Flap Repair with Z Plasty Repair in a Case Series of 40 Patients.

Authors:  Sharad Hernot; Raman Wadhera; Madhuri Kaintura; Sandeep Bhukar; Dheeraj Shashikumar Pillai; Usha Sehrawat; Jitu Sam George
Journal:  Aesthetic Plast Surg       Date:  2016-10-04       Impact factor: 2.326

View more
  1 in total

1.  Local skin flap procedure for repair of rectovaginal fistula: A case report.

Authors:  Kazunosuke Yamada; Taro Hirose; Hitoshi Ojima
Journal:  Int J Surg Case Rep       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.